Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations-Reference-Cited by-同舟云学术

Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations

Published:2023-04-03 Issue:4 Volume:19 Page:189-202
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Schoretsanitis Georgios¹²³^ORCID,Meyer Jonathan M.⁴^ORCID,Conca Andreas⁵,Hiemke Christoph⁶^ORCID

Affiliation:

1. Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland

2. The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY, USA

3. Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA

4. Department of Psychiatry, University of California San Diego School of Medicine, La Jolla, CA, USA

5. Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy

6. Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2220962

Reference100 articles.

1. Trends in the Use of Long-Acting Injectable Antipsychotics in the Province of Manitoba, Canada

2. Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia

3. Suicide attempts in people with schizophrenia before and after participating in an intensive case managed community program: A 20-year follow-up

4. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

5. Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposing a novel approach for the long-term use of monthly paliperidone palmitate: adjusting injection dose versus adjusting injection interval;Expert Opinion on Drug Metabolism & Toxicology;2024-07-12

2. Assessing the impact of long‐acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital;Journal of Psychiatric and Mental Health Nursing;2024-06-22

3. The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment;The World Journal of Biological Psychiatry;2024-06-21

4. Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions;Expert Review of Clinical Pharmacology;2024-06-04

5. Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond;Schizophrenia Research;2024-06